RBC Capital upgraded Bio-Techne (TECH) to Outperform from Sector Perform with a $73 price target
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TECH:
- CoreWeave upgraded, Instacart downgraded: Wall Street’s top analyst calls
- Bio-Techne upgraded to Buy from Neutral at Citi
- Strategic Divestiture and Focus on Core Strengths Justify Buy Rating for Bio-Techne
- Bio-Techne’s Strong Q4 Performance and Strategic Moves Justify Buy Rating
- Bio-Techne Reports Solid Q4 2025 Results Amid Strategic Shift